>> HOMEPAGE

Multiple Sclerosis

"High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis"

Nieves J; Cosman F; Herbert J; Shen V; Lindsay R, Neurology 1994 Sep;44(9):1687-92

ABSTRACT: BACKGROUND: Female patients with multiple sclerosis (MS) are at risk for osteoporosis because of gender, immobility, and corticosteroid use. METHODS: Bone mineral density (BMD) was measured by dual x-ray absorptiometry in 80 female MS patients admitted to a tertiary care hospital. All patients completed a questionnaire that included measurements of dietary intake and sunlight exposure. Biochemical indices of bone metabolism and turnover were measured in a random sample of 52 patients. RESULTS: BMD of the lumbar spine and femoral neck was 1 to 2 SDs lower in MS women compared with a healthy reference population. BMD was lower in patients with more severe MS. The mean 25(OH)D level of the sample population (43 nmol/l) was in the insufficient range, and 12 patients (23%) had frank vitamin D deficiency (< 25 nmol/l). BMD and age-related BMD (z scores) at all skeletal sites measured were lowest when 25(OH)D levels were deficient. Parathyroid hormone (PTH) was frankly elevated in 13% of patients. PTH levels were negatively correlated with 25(OH)D levels and with BMD. Dietary intake of vitamin D was below the recommended level in 80% of patients, and 40% reported no weekly sunlight exposure. After controlling for age, cumulative steroid use was not a determinant of BMD. CONCLUSIONS: BMD was significantly reduced in female MS patients, which might increase fracture risk two- to threefold. Vitamin D deficiency with secondary hyperparathyroidism is prevalent and is probably a significant cause of low BMD in this population. Vitamin D deficiency in the female MS patient might be safely and inexpensively corrected by the routine use of vitamin D supplements.

Sitemap

Was ist neu:

Unsere Verantwortung für die Schaffung einer Welt der Gesundheit, des Friedens und der sozialen Gerechtigkeit

Neue Studie würdigt die Rolle von Vitamin C bei der Reduktion von herzkreislaufbedingter Sterblichkeit

Mehr Kranke bitte! – Abrechnungsbetrügerei mit System

Wenn Arzneimittel verpflichtend werden: Pharma stiftet Gerichte dazu an, Opiod-Abhängige einem Drogenprogramm zu unterwerfen – mit Kosten von $1000 je Injektion

Depressionen infolge Vitamin B-Mangel – ein neuer wissenschaftlicher Review steigert die Beweislast

Neue Metaanalyse stellt wiederum den Nutzen von Magnesium bei Bluthochdruck unter Beweis

Die Cholesterin-Herzinfarkt-Hypothese ist “tot”, bestätigt die britische Königliche Pharmazeutische Gesellschaft

Erfrischung pur – Über die Bedeutung von Trinkwasser im menschlichen Körper

» Natürliche Gesundheit

» "Geschäft m. d. Krankheit"

» Internationale Kampagne

» Dr. Raths Offene Briefe

» Studien weltweit

» Studien auf Deutsch

» Helfen Sie mit!

» Codex Alimentarius

» Dossiers

» Sitemap

Dr. Rath Health Foundation auf Facebook Dr. Rath Health Foundation auf YouTube Dr. Rath Health Foundation auf Twitter RSS
 © 2017 Dr. Rath Health Foundation | Kontakt | Impressum | RSS Feed